Literature DB >> 20432810

Biochemical markers of bone cell activity in children with type 1 diabetes mellitus.

Agnieszka Pater1, Grazyna Sypniewska, Olgierd Pilecki.   

Abstract

AIMS: To evaluate bone turnover in children with type 1 diabetes mellitus (DM1) at onset, after 3 and 12 months of treatment, and in children with longer duration of disease, and its association with glycemic control. PATIENTS AND METHODS: 17 children with DM1 at onset, 30 with DM1 of longer duration and 45 controls participated in the study. Tartrate-resistant acid phosphatase 5b (TRACP5b), crosslinked C-terminal telopeptides of type I collagen (CTX) and osteocalcin (OC) were assessed.
RESULTS: At onset of DM1 osteocalcin (p < 0.0003) and log CTX (p < 0.003) were lower than in controls but returned to reference levels after 3 months of therapy. TRACP5b in children with DM1 increased gradually and after 12 months was higher than at onset (p < 0.03). OC at onset inversely correlated with HbA1c (r = -0.40, p = 0.03). In children with DM1 of longer duration and HbA1c > 6.5%, sex-dependent differences were found in OC and CTX. Girls with HbA1 > 6.5% had lower OC and CTX than controls (p < 0.005, p < 0.003). Inverse correlations were found between HbA1c and OC and CTX (r = -0.50, p = 0.04; r = -0.49, p = 0.03).
CONCLUSIONS: Proper glycemic control has a beneficial influence on bone turnover, which may prevent low bone mass in adulthood.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20432810     DOI: 10.1515/jpem.2010.23.1-2.81

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  15 in total

1.  Determinants of undercarboxylated and carboxylated osteocalcin concentrations in type 1 diabetes.

Authors:  K M Thrailkill; C-H Jo; G E Cockrell; C S Moreau; C K Lumpkin; J L Fowlkes
Journal:  Osteoporos Int       Date:  2011-11-09       Impact factor: 4.507

2.  Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetes.

Authors:  Ernesto Maddaloni; Luca D'Onofrio; Angelo Lauria; Anna Rita Maurizi; Rocky Strollo; Andrea Palermo; Nicola Napoli; Silvia Angeletti; Paolo Pozzilli; Silvia Manfrini
Journal:  J Endocrinol Invest       Date:  2014-05-24       Impact factor: 4.256

Review 3.  Epidemiology of Skeletal Health in Type 1 Diabetes.

Authors:  David R Weber; George Schwartz
Journal:  Curr Osteoporos Rep       Date:  2016-12       Impact factor: 5.096

Review 4.  The role of osteocalcin in human glucose metabolism: marker or mediator?

Authors:  Sarah L Booth; Amanda Centi; Steven R Smith; Caren Gundberg
Journal:  Nat Rev Endocrinol       Date:  2012-11-13       Impact factor: 43.330

5.  Collagen fibril surface displays a constellation of sites capable of promoting fibril assembly, stability, and hemostasis.

Authors:  J P R O Orgel; O Antipova; I Sagi; A Bitler; D Qiu; R Wang; Y Xu; J D San Antonio
Journal:  Connect Tissue Res       Date:  2010-11-30       Impact factor: 3.417

Review 6.  Assessment of bone quality in patients with diabetes mellitus.

Authors:  N Jiang; W Xia
Journal:  Osteoporos Int       Date:  2018-05-07       Impact factor: 4.507

7.  Ursolic acid derivative ameliorates streptozotocin-induced diabestic bone deleterious effects in mice.

Authors:  Su-Guo Yu; Cheng-Jie Zhang; Xiu-E Xu; Ji-Hua Sun; Li Zhang; Peng-Fei Yu
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

8.  Estrogen Deficiency Exacerbates Type 1 Diabetes-Induced Bone TNF-α Expression and Osteoporosis in Female Mice.

Authors:  Sandi Raehtz; Hayley Bierhalter; Daniel Schoenherr; Narayanan Parameswaran; Laura R McCabe
Journal:  Endocrinology       Date:  2017-07-01       Impact factor: 4.736

Review 9.  Diabetes mellitus and osteoporosis.

Authors:  Robert Sealand; Christie Razavi; Robert A Adler
Journal:  Curr Diab Rep       Date:  2013-06       Impact factor: 4.810

10.  Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.

Authors:  C Tsentidis; D Gourgiotis; L Kossiva; A Doulgeraki; A Marmarinos; A Galli-Tsinopoulou; K Karavanaki
Journal:  Osteoporos Int       Date:  2015-11-20       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.